 | • レポートコード：GIR-2104Z03143 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、コレラワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コレラワクチンの種類別市場規模（Dukoral、Shanchol、Vaxchora、その他）、用途別市場規模（経口、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・コレラワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Shantha Biotechnics Private Limited、PaxVax, Inc.、Valneva SE、Merck and Co., Inc.、GlaxoSmithKline plc (GSK)、Astellas Pharma, Inc.、Pfizer, Inc.、Emergent BioSolutions, Inc.、Mitsubishi Tanabe Pharma Corporation、Takeda Pharmaceutical Co., Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Dukoral、Shanchol、Vaxchora、その他 ・用途別分析2016年-2026年：経口、その他 ・コレラワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・コレラワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・コレラワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コレラワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・コレラワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cholera Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cholera Vaccines size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Cholera Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cholera Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dukoral
Shanchol
Vaxchora
Others
Market segment by Application, can be divided into
Oral
Others
Market segment by players, this report covers
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cholera Vaccines
1.2 Classification of Cholera Vaccines by Type
1.2.1 Overview: Global Cholera Vaccines Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cholera Vaccines Revenue Market Share by Type in 2020
1.2.3 Dukoral
1.2.4 Shanchol
1.2.5 Vaxchora
1.2.6 Others
1.3 Global Cholera Vaccines Market by Application
1.3.1 Overview: Global Cholera Vaccines Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Oral
1.3.3 Others
1.4 Global Cholera Vaccines Market Size & Forecast
1.5 Global Cholera Vaccines Market Size and Forecast by Region
1.5.1 Global Cholera Vaccines Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cholera Vaccines Market Size by Region, (2016-2021)
1.5.3 North America Cholera Vaccines Market Size and Prospect (2016-2026)
1.5.4 Europe Cholera Vaccines Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cholera Vaccines Market Size and Prospect (2016-2026)
1.5.6 South America Cholera Vaccines Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cholera Vaccines Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cholera Vaccines Market Drivers
1.6.2 Cholera Vaccines Market Restraints
1.6.3 Cholera Vaccines Trends Analysis
2 Company Profiles
2.1 Shantha Biotechnics Private Limited
2.1.1 Shantha Biotechnics Private Limited Details
2.1.2 Shantha Biotechnics Private Limited Major Business
2.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
2.1.4 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Shantha Biotechnics Private Limited Recent Developments and Future Plans
2.2 PaxVax, Inc.
2.2.1 PaxVax, Inc. Details
2.2.2 PaxVax, Inc. Major Business
2.2.3 PaxVax, Inc. Cholera Vaccines Product and Solutions
2.2.4 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 PaxVax, Inc. Recent Developments and Future Plans
2.3 Valneva SE
2.3.1 Valneva SE Details
2.3.2 Valneva SE Major Business
2.3.3 Valneva SE Cholera Vaccines Product and Solutions
2.3.4 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Valneva SE Recent Developments and Future Plans
2.4 Merck and Co., Inc.
2.4.1 Merck and Co., Inc. Details
2.4.2 Merck and Co., Inc. Major Business
2.4.3 Merck and Co., Inc. Cholera Vaccines Product and Solutions
2.4.4 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck and Co., Inc. Recent Developments and Future Plans
2.5 GlaxoSmithKline plc (GSK)
2.5.1 GlaxoSmithKline plc (GSK) Details
2.5.2 GlaxoSmithKline plc (GSK) Major Business
2.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
2.5.4 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GlaxoSmithKline plc (GSK) Recent Developments and Future Plans
2.6 Astellas Pharma, Inc.
2.6.1 Astellas Pharma, Inc. Details
2.6.2 Astellas Pharma, Inc. Major Business
2.6.3 Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
2.6.4 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Astellas Pharma, Inc. Recent Developments and Future Plans
2.7 Pfizer, Inc.
2.7.1 Pfizer, Inc. Details
2.7.2 Pfizer, Inc. Major Business
2.7.3 Pfizer, Inc. Cholera Vaccines Product and Solutions
2.7.4 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer, Inc. Recent Developments and Future Plans
2.8 Emergent BioSolutions, Inc.
2.8.1 Emergent BioSolutions, Inc. Details
2.8.2 Emergent BioSolutions, Inc. Major Business
2.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
2.8.4 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Emergent BioSolutions, Inc. Recent Developments and Future Plans
2.9 Mitsubishi Tanabe Pharma Corporation
2.9.1 Mitsubishi Tanabe Pharma Corporation Details
2.9.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
2.9.4 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
2.10 Takeda Pharmaceutical Co., Ltd.
2.10.1 Takeda Pharmaceutical Co., Ltd. Details
2.10.2 Takeda Pharmaceutical Co., Ltd. Major Business
2.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
2.10.4 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cholera Vaccines Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cholera Vaccines Players Market Share
3.2.2 Top 10 Cholera Vaccines Players Market Share
3.2.3 Market Competition Trend
3.3 Cholera Vaccines Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cholera Vaccines Revenue and Market Share by Type (2016-2021)
4.2 Global Cholera Vaccines Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cholera Vaccines Revenue Market Share by Application (2016-2021)
5.2 Cholera Vaccines Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cholera Vaccines Revenue by Type (2016-2026)
6.2 North America Cholera Vaccines Revenue by Application (2016-2026)
6.3 North America Cholera Vaccines Market Size by Country
6.3.1 North America Cholera Vaccines Revenue by Country (2016-2026)
6.3.2 United States Cholera Vaccines Market Size and Forecast (2016-2026)
6.3.3 Canada Cholera Vaccines Market Size and Forecast (2016-2026)
6.3.4 Mexico Cholera Vaccines Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cholera Vaccines Revenue by Type (2016-2026)
7.2 Europe Cholera Vaccines Revenue by Application (2016-2026)
7.3 Europe Cholera Vaccines Market Size by Country
7.3.1 Europe Cholera Vaccines Revenue by Country (2016-2026)
7.3.2 Germany Cholera Vaccines Market Size and Forecast (2016-2026)
7.3.3 France Cholera Vaccines Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cholera Vaccines Market Size and Forecast (2016-2026)
7.3.5 Russia Cholera Vaccines Market Size and Forecast (2016-2026)
7.3.6 Italy Cholera Vaccines Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cholera Vaccines Revenue by Type (2016-2026)
8.2 Asia-Pacific Cholera Vaccines Revenue by Application (2016-2026)
8.3 Asia-Pacific Cholera Vaccines Market Size by Region
8.3.1 Asia-Pacific Cholera Vaccines Revenue by Region (2016-2026)
8.3.2 China Cholera Vaccines Market Size and Forecast (2016-2026)
8.3.3 Japan Cholera Vaccines Market Size and Forecast (2016-2026)
8.3.4 South Korea Cholera Vaccines Market Size and Forecast (2016-2026)
8.3.5 India Cholera Vaccines Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cholera Vaccines Market Size and Forecast (2016-2026)
8.3.7 Australia Cholera Vaccines Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cholera Vaccines Revenue by Type (2016-2026)
9.2 South America Cholera Vaccines Revenue by Application (2016-2026)
9.3 South America Cholera Vaccines Market Size by Country
9.3.1 South America Cholera Vaccines Revenue by Country (2016-2026)
9.3.2 Brazil Cholera Vaccines Market Size and Forecast (2016-2026)
9.3.3 Argentina Cholera Vaccines Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cholera Vaccines Revenue by Type (2016-2026)
10.2 Middle East & Africa Cholera Vaccines Revenue by Application (2016-2026)
10.3 Middle East & Africa Cholera Vaccines Market Size by Country
10.3.1 Middle East & Africa Cholera Vaccines Revenue by Country (2016-2026)
10.3.2 Turkey Cholera Vaccines Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cholera Vaccines Market Size and Forecast (2016-2026)
10.3.4 UAE Cholera Vaccines Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cholera Vaccines Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cholera Vaccines Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cholera Vaccines Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cholera Vaccines Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cholera Vaccines Revenue Market Share by Region (2021-2026)
Table 6. Shantha Biotechnics Private Limited Corporate Information, Head Office, and Major Competitors
Table 7. Shantha Biotechnics Private Limited Major Business
Table 8. Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
Table 9. Shantha Biotechnics Private Limited Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. PaxVax, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. PaxVax, Inc. Major Business
Table 12. PaxVax, Inc. Cholera Vaccines Product and Solutions
Table 13. PaxVax, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Valneva SE Corporate Information, Head Office, and Major Competitors
Table 15. Valneva SE Major Business
Table 16. Valneva SE Cholera Vaccines Product and Solutions
Table 17. Valneva SE Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck and Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Merck and Co., Inc. Major Business
Table 20. Merck and Co., Inc. Cholera Vaccines Product and Solutions
Table 21. Merck and Co., Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GlaxoSmithKline plc (GSK) Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline plc (GSK) Major Business
Table 24. GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
Table 25. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Astellas Pharma, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Astellas Pharma, Inc. Major Business
Table 28. Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
Table 29. Astellas Pharma, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer, Inc. Major Business
Table 32. Pfizer, Inc. Cholera Vaccines Product and Solutions
Table 33. Pfizer, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Emergent BioSolutions, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Emergent BioSolutions, Inc. Major Business
Table 36. Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
Table 37. Emergent BioSolutions, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Mitsubishi Tanabe Pharma Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Mitsubishi Tanabe Pharma Corporation Major Business
Table 40. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
Table 41. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Takeda Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Takeda Pharmaceutical Co., Ltd. Major Business
Table 44. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
Table 45. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Cholera Vaccines Revenue (USD Million) by Players (2019-2021)
Table 47. Global Cholera Vaccines Revenue Share by Players (2019-2021)
Table 48. Breakdown of Cholera Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Cholera Vaccines Players Head Office, Products and Services Provided
Table 50. Cholera Vaccines Mergers & Acquisitions in the Past Five Years
Table 51. Cholera Vaccines New Entrants and Expansion Plans
Table 52. Global Cholera Vaccines Revenue (USD Million) by Type (2016-2021)
Table 53. Global Cholera Vaccines Revenue Share by Type (2016-2021)
Table 54. Global Cholera Vaccines Revenue Forecast by Type (2021-2026)
Table 55. Global Cholera Vaccines Revenue by Application (2016-2021)
Table 56. Global Cholera Vaccines Revenue Forecast by Application (2021-2026)
Table 57. North America Cholera Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Cholera Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Cholera Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Cholera Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Cholera Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Cholera Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Cholera Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Cholera Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Cholera Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Cholera Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Cholera Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Cholera Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Cholera Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Cholera Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Cholera Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Cholera Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Cholera Vaccines Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Cholera Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Cholera Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Cholera Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Cholera Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Cholera Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Cholera Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Cholera Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Cholera Vaccines Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Cholera Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Cholera Vaccines Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Cholera Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Cholera Vaccines Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Cholera Vaccines Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cholera Vaccines Picture
Figure 2. Global Cholera Vaccines Revenue Market Share by Type in 2020
Figure 3. Dukoral
Figure 4. Shanchol
Figure 5. Vaxchora
Figure 6. Others
Figure 7. Cholera Vaccines Revenue Market Share by Application in 2020
Figure 8. Oral Picture
Figure 9. Others Picture
Figure 10. Global Cholera Vaccines Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Cholera Vaccines Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Cholera Vaccines Revenue Market Share by Region (2016-2026)
Figure 13. Global Cholera Vaccines Revenue Market Share by Region in 2020
Figure 14. North America Cholera Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Cholera Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Cholera Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Cholera Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Cholera Vaccines Market Drivers
Figure 19. Cholera Vaccines Market Restraints
Figure 20. Cholera Vaccines Market Trends
Figure 21. Shantha Biotechnics Private Limited Recent Developments and Future Plans
Figure 22. PaxVax, Inc. Recent Developments and Future Plans
Figure 23. Valneva SE Recent Developments and Future Plans
Figure 24. Merck and Co., Inc. Recent Developments and Future Plans
Figure 25. GlaxoSmithKline plc (GSK) Recent Developments and Future Plans
Figure 26. Astellas Pharma, Inc. Recent Developments and Future Plans
Figure 27. Pfizer, Inc. Recent Developments and Future Plans
Figure 28. Emergent BioSolutions, Inc. Recent Developments and Future Plans
Figure 29. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
Figure 30. Takeda Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Figure 32. Global Cholera Vaccines Revenue Share by Players in 2020
Figure 33. Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Cholera Vaccines Revenue Market Share in 2020
Figure 35. Global Top 10 Players Cholera Vaccines Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Cholera Vaccines Revenue Share by Type in 2020
Figure 38. Global Cholera Vaccines Market Share Forecast by Type (2021-2026)
Figure 39. Global Cholera Vaccines Revenue Share by Application in 2020
Figure 40. Global Cholera Vaccines Market Share Forecast by Application (2021-2026)
Figure 41. North America Cholera Vaccines Sales Market Share by Type (2016-2026)
Figure 42. North America Cholera Vaccines Sales Market Share by Application (2016-2026)
Figure 43. North America Cholera Vaccines Revenue Market Share by Country (2016-2026)
Figure 44. United States Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Cholera Vaccines Sales Market Share by Type (2016-2026)
Figure 48. Europe Cholera Vaccines Sales Market Share by Application (2016-2026)
Figure 49. Europe Cholera Vaccines Revenue Market Share by Country (2016-2026)
Figure 50. Germany Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Cholera Vaccines Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Cholera Vaccines Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Cholera Vaccines Revenue Market Share by Region (2016-2026)
Figure 58. China Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Cholera Vaccines Sales Market Share by Type (2016-2026)
Figure 65. South America Cholera Vaccines Sales Market Share by Application (2016-2026)
Figure 66. South America Cholera Vaccines Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Cholera Vaccines Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Cholera Vaccines Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Cholera Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Cholera Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の経口コレラワクチン市場 2021：企業別、地域別、種類・用途別 The Oral Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界のコレラワクチン（経口用）市場 2021：企業別、地域別、種類・用途別 The Cholera Vaccine (Oral Route) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のコレラ治療市場規模・現状・予測（2021年-2027年） Cholera is an infectious disease that causes severe watery diarrhea, which can lead to dehydration and even death if untreated. Market Analysis and Insights: Global Cholera Treatment Market The global Cholera Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- 世界のmRNAワクチン市場規模・現状・予測（2021年-2027年） When the mRNA encoding the antigenic protein is injected into the human body, the antigenic protein can be synthesized in the body, thus causing the human immune response against the pathogen infection, namely the mRNA vaccine. In 2021, the global mRNA Vaccines market size will be US$ XX million and…
- 世界の新型コロナウイルス感染症ワクチン・治療薬市場規模・現状・予測（2021年-2027年） In 2020, the global COVID-19 Vaccines & Therapeutics market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2021-2026. This report focuses on the global COVID-19 Vaccines & Therapeutics status, future forecast, growth opportunity, …